Guadalupe Miranda-Novales

Dr. Guadalupe Miranda-Novales

Mexican Social Security Institute, Mexico City, Ciudad de México, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
FSFortino Solórzano-Santos
Fortino Solórzano-Santos
Guadalupe Miranda-NovalesGuadalupe Miranda-Novales
Guadalupe Miranda-Novales

1 March 2010 in American Journal of Infection Control
Verified
Journal Article
Closed access
VRVictor D. Rosenthal
Victor D. Rosenthal
DMDennis G. Maki
Dennis G. Maki
SJSilom Jamulitrat
Silom Jamulitrat
EMEduardo A. Medeiros
Eduardo A. Medeiros
STSubhash Kumar Todi
Subhash Kumar Todi
MSMaría Eugenia Guzmán Siritt
María Eugenia Guzmán Siritt

1 October 2021 in American Journal of Infection Control
Verified
Journal Article
Closed access
VRVictor Daniel Rosenthal
Victor Daniel Rosenthal
WDWieslawa Duszynska
Wieslawa Duszynska
BIBat-Erdene Ider
Bat-Erdene Ider
VGVaidotas Gurskis
Vaidotas Gurskis
MAMajeda A. Al-Ruzzieh
Majeda A. Al-Ruzzieh
NENurettin Erben
Nurettin Erben

18 April 2022 in Archives of Medical Research
Verified
Journal Article
Closed access
MVMiguel A Villasis-Keever
Miguel A Villasis-Keever
MLMardia López-Alarcón
Mardia López-Alarcón
Guadalupe Miranda-NovalesGuadalupe Miranda-Novales
Guadalupe Miranda-Novales
JZJessie N Zurita-Cruz
Jessie N Zurita-Cruz
ABAly S Barrada-Vázquez
Aly S Barrada-Vázquez
IOISRAEL ORTEGA
ISRAEL ORTEGA

1 July 2012 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
VRVictor D. Md Rosenthal
Victor D. Md Rosenthal
WJWilliam R. Jarvis
William R. Jarvis
SJSilom Jamulitrat
Silom Jamulitrat
CSCristiane Pavanello Rodrigues Silva
Cristiane Pavanello Rodrigues Silva
BRBala Ramachandran
Bala Ramachandran
KJKushlani Jayatilleke
Kushlani Jayatilleke
Objectives: We report the results of the International Nosocomial Infection Control Consortium prospective surveillance study from January 2004 to December 2009 in 33 pediatric intensive care units of 16 countries and the impact of being in a private vs. public hospital and the income country level on device-associated health care-associated infection rates. Additionally, we aim to compare these findings with the results of the Centers for Disease Control and Prevention National Healthcare Safety Network annual report to show the differences between developed and developing countries regarding device-associated health care-associated infection rates. Patients: A prospective cohort, active device-associated health care-associated infection surveillance study was conducted on 23,700 patients in International Nosocomial Infection Control Consortium pediatric intensive care units. Methods: The protocol and methodology implemented were developed by International Nosocomial Infection Control Consortium. Data collection was performed in the participating intensive care units. Data uploading and analyses were conducted at International Nosocomial Infection Control Consortium headquarters on proprietary software. Device-associated health care-associated infection rates were recorded by applying Centers for Disease Control and Prevention National Healthcare Safety Network device-associated infection definitions, and the impact of being in a private vs. public hospital and the income country level on device-associated infection risk was evaluated. Interventions: None. Measurements and Main Results: Central line-associated bloodstream infection rates were similar in private, public, or academic hospitals (7.3 vs. 8.4 central line-associated bloodstream infection per 1,000 catheter-days [p < .35 vs. 8.2; p < .42]). Central line-associated bloodstream infection rates in lower middle-income countries were higher than low-income countries or upper middle-income countries (12.2 vs. 5.5 central line-associated bloodstream infections per 1,000 catheter-days [p < .02 vs. 7.0; p < .001]). Catheter-associated urinary tract infection rates were similar in academic, public and private hospitals: (4.2 vs. 5.2 catheter-associated urinary tract infection per 1,000 catheter-days [p = .41 vs. 3.0; p = .195]). Catheter-associated urinary tract infection rates were higher in lower middle-income countries than low-income countries or upper middle-income countries (5.9 vs. 0.6 catheter-associated urinary tract infection per 1,000 catheter-days [p < .004 vs. 3.7; p < .01]). Ventilator-associated pneumonia rates in academic hospitals were higher than private or public hospitals: (8.3 vs. 3.5 ventilator-associated pneumonias per 1,000 ventilator-days [p < .001 vs. 4.7; p < .001]). Lower middle-income countries had higher ventilator-associated pneumonia rates than low-income countries or upper middle-income countries: (9.0 vs. 0.5 per 1,000 ventilator-days [p < .001 vs. 5.4; p < .001]). Hand hygiene compliance rates were higher in public than academic or private hospitals (65.2% vs. 54.8% [p < .001 vs. 13.3%; p < .01]). Conclusions: Country socioeconomic level influence device-associated infection rates in developing countries and need to be considered when comparing device-associated infections from one country to another.

1 December 1996 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
Guadalupe Miranda-NovalesGuadalupe Miranda-Novales
Guadalupe Miranda-Novales
CKC Kelly
C Kelly
FSF Solorzano
F Solorzano
BLB Leanos
B Leanos
RCR Coria
R Coria
JPJ E Patterson
J E Patterson
Serratia marcescens is a well-known cause of nosocomial infections and outbreaks, particularly in critically ill neonates and immunocompromised patients. Numerous methods have been proposed for typing. We used pulsed-field gel electrophoresis (PFGE) typing to analyze an outbreak in a neonatal intensive care unit (NICU). We included 23 patient isolates from an outbreak (March to July 1995), and 10 patient isolates from different wards during the same time period. PFGE of whole-cell DNA digested by SpeI was used as a marker of strain identity. The most common presentation of the infection was sepsis in 18 of 23 (78%) neonates. Only four different biotypes were identified; biotype A8d accounted for 84% of the strains. PFGE typing revealed two clones responsible for two different clonal strain dissemination outbreaks from March to July, with 24 patient isolates being pattern A and 4 patient isolates being pattern E. PFGE typing suggests cross transmission between patients in the NICU and other wards. The isolates from 5 other patients showed distinct PFGE patterns. Extensive investigation and cultures failed to identify any environmental or staff reservoir of S. marcescens. This is one of the first reports applying PFGE to the study of S. marcescens, and this method was a useful marker of strain identity. PFGE typing distinguished strains which appeared to be the same by biotyping.